
|Slideshows|September 26, 2017
A New Drug in Development for Negative Symptoms
Author(s)Brian Miller, MD, PhD, MPH
Is an effective, well-tolerated treatment for the negative symptoms of schizophrenia on the horizon?
Advertisement
View the slides in PDF format.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
New 6-Month Data From Second Phase 3 Trial Confirms Rapid Effect of COMP360 for TRD
2
Filling the Gap Between IV Ketamine Clinical Use and Evidence-Based Standards
3
Phase 2 Trial Initiated for Briumvi for Treatment-Resistant Schizophrenia
4
Developments in Cannabis Withdrawal and Addiction Treatment
5











